Journal article

P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM)

Paul G Richardson, Suzanne Trudel, Natalie S Callander, Ajay Nooka, Kevin Song, Katarina Uttervall, Monique C Minnema, Paula Rodríguez-Otero, Herbert Struemper, Anne Yeakey, Rocio Montes de Oca, L Mary Smith, Nicola Jackson, Morrys Kaisermann, Ellie Im, Frank G Basile, Christoph M Ahlers, Beata Holkova, Ira Gupta, Brandon E Kremer Show all

Clinical Lymphoma Myeloma and Leukemia | Elsevier BV | Published : 2021